Menu Close

Congrats to Dr. Tasdemir and colleagues on their new BioRxiv pre-print!

Congratulations to Nilgun Tasdemir on her new publication!

Proteomic and Transcriptomic Profiling Identifies Mediators of Anchorage-Independent Growth and Roles of Inhibitor of Differentiation Proteins in Invasive Lobular Breast Cancer –

Abstract. BACKGROUND: Invasive lobular carcinoma (ILC) is a histological subtype of breast cancer with distinct molecular and clinical features from the more common subtype invasive lobular carcinoma (IDC)

Dr. Adrian Lee interviewed on the “Do-Goodery Podcast: The Cancer Episode”!

Dr. Adrian Lee was recently interviewed for the “Do-Goodery Podcast: The Cancer Episode” to, as described by their website, “discuss what a jerk Cancer is. We Take Astro 101, learn about new weapons in the fight against Cancer, and how to support those who’ve received a Cancer diagnosis.”

Listen here:


Dr. Oesterreich discusses ILC at NWMBCC in Seattle

Steffi meets with members of LBCA advocacy group (, and discusses progress and challenges for ILC research at the Northwest Metastatic Breast Cancer Conference (NWMBCC).

The presentation was live streamed, and can be seen here:

Of note, Leigh Pate, founder of LBCA, receives the Beth Caldwell Breakthrough Leadership award.